Pfizer Inc. et al v. Alembic Pharmaceuticals, Inc. et al
| Pfizer Inc., Warner-Lambert Company LLC and PF PRISM IMB B.V. |
| Alembic Pharmaceuticals, Ltd. and Alembic Pharmaceuticals, Inc. |
| 1:2020cv01392 |
| October 16, 2020 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 9, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent none for Alembic Pharmaceuticals, Ltd.; Corporate Parent Alembic Global Holdings S/A for Alembic Pharmaceuticals, Inc. filed by Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals, Ltd.. (Palapura, Bindu) |
| Filing 9 ANSWER to #1 Complaint, by Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals, Ltd..(Palapura, Bindu) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:20-cv-01392-UNA, 1:20-cv-01393-UNA, 1:20-cv-01395-UNA, 1:20-cv-01396-UNA(nms) |
| Filing 8 SUMMONS Returned Executed by Warner-Lambert Company LLC, Pfizer Inc., PF PRISM IMB B.V.. Alembic Pharmaceuticals, Ltd. served on 10/19/2020, answer due 11/9/2020. (Dellinger, Megan) |
| Filing 7 SUMMONS Returned Executed by Warner-Lambert Company LLC, Pfizer Inc., PF PRISM IMB B.V.. Alembic Pharmaceuticals, Inc. served on 10/19/2020, answer due 11/9/2020. (Dellinger, Megan) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (myr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for PF PRISM IMB B.V., Warner-Lambert Company LLC. Pfizer Inc. has no parent corporation. filed by PF PRISM IMB B.V., Pfizer Inc., Warner-Lambert Company LLC. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,723,730 B2. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than September 15, 2020. Date of Expiration of Patent: February 8, 2034. Thirty Month Stay Deadline: See Attached (myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT filed against Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3271108.) - filed by Warner-Lambert Company LLC, Pfizer Inc., PF PRISM IMB B.V. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
